Akebia Therapeutics Inc
NASDAQ:AKBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
|
M
|
Marsh & McLennan Companies Inc
SWB:MSN
|
US |
|
Z
|
Zimmer Biomet Holdings, Inc
SWB:ZIM
|
US |
|
N
|
National Vision Holdings Inc
SWB:7NV
|
US |
|
A
|
Avricore Health Inc
OTC:AVCRF
|
CA |
|
M
|
Matichon PCL
SET:MATI
|
TH |
|
Z
|
Zhejiang Expressway Co Ltd
XMUN:ZHJ
|
CN |
|
D
|
Dgenx Co Ltd
KOSDAQ:113810
|
KR |
|
S
|
SandRidge Energy Inc
F:SA2D
|
US |
|
MRF Ltd
BSE:500290
|
IN |
|
I
|
Iridium Communications Inc
SWB:6IC
|
US |
|
C
|
Cleveland-Cliffs Inc
XMUN:CVA
|
US |
|
Transport Corporation of India Ltd
BSE:532349
|
IN |
|
St James's Place PLC
OTC:STJPF
|
UK |
|
S
|
SLM Corp
DUS:SM1
|
US |
|
P
|
Powszechna Kasa Oszczednosci Bank Polski SA
XMUN:P9O
|
PL |
|
E
|
Endesa SA
SWB:ENA
|
ES |
|
Advantest Corp
OTC:ATEYY
|
JP |
|
AES Corp
NYSE:AES
|
US |
|
S
|
Softcen Co Ltd
KOSDAQ:032685
|
KR |
|
Walmart Inc
NASDAQ:WMT
|
US |
|
VF Corp
NYSE:VFC
|
US |
|
Relx PLC
LSE:REL
|
UK |
|
Convano Inc
TSE:6574
|
JP |
Bankruptcy Probability
Akebia Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Akebia Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
207.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
197.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
61B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Akebia Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Akebia Therapeutics Inc has total debt of 156.9m USD. This includes both short-term (0 USD) and long-term (156.9m USD) debt.
You can find a full breakdown on its Balance Sheet.